Watson Pharmaceuticals, Inc. (NYSE: WPI) to acquire Specifar Pharmaceuticals S.A. for €400 million, or about $562 million.

As a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE